Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials
分子 BCR-ABL1 监测系统的诊断性能可能会影响慢性粒细胞白血病 (CML) 患者是否被纳入终止试验。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0214305
Spiess, Birgit; Rinaldetti, Sébastien; Naumann, Nicole; Galuschek, Norbert; Kossak-Roth, Ute; Wuchter, Patrick; Tarnopolscaia, Irina; Rose, Diana; Voskanyan, Astghik; Fabarius, Alice; Hofmann, Wolf-Karsten; Saußele, Susanne; Seifarth, Wolfgang
